X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA TTK HEALTHCARE NATCO PHARMA/
TTK HEALTHCARE
 
P/E (TTM) x 30.5 33.5 91.0% View Chart
P/BV x 23.1 6.2 374.4% View Chart
Dividend Yield % 0.5 0.5 105.2%  

Financials

 NATCO PHARMA   TTK HEALTHCARE
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
TTK HEALTHCARE
Mar-14
NATCO PHARMA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs877663 132.2%   
Low Rs424399 106.1%   
Sales per share (Unadj.) Rs223.4535.6 41.7%  
Earnings per share (Unadj.) Rs31.115.9 194.8%  
Cash flow per share (Unadj.) Rs40.320.0 201.1%  
Dividends per share (Unadj.) Rs5.004.00 125.0%  
Dividend yield (eoy) %0.80.8 102.1%  
Book value per share (Unadj.) Rs219.5137.6 159.5%  
Shares outstanding (eoy) m33.077.77 425.6%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.91.0 293.5%   
Avg P/E ratio x20.933.3 62.8%  
P/CF ratio (eoy) x16.126.5 60.9%  
Price / Book Value ratio x3.03.9 76.7%  
Dividend payout %16.125.1 64.2%   
Avg Mkt Cap Rs m21,5044,127 521.0%   
No. of employees `000NA1.7 0.0%   
Total wages/salary Rs m1,128607 185.9%   
Avg. sales/employee Rs ThNM2,436.7-  
Avg. wages/employee Rs ThNM355.2-  
Avg. net profit/employee Rs ThNM72.5-  
INCOME DATA
Net Sales Rs m7,3894,162 177.5%  
Other income Rs m16761 273.0%   
Total revenues Rs m7,5564,223 178.9%   
Gross profit Rs m1,793197 909.8%  
Depreciation Rs m30432 960.3%   
Interest Rs m36630 1,224.7%   
Profit before tax Rs m1,290197 655.7%   
Minority Interest Rs m460-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m30973 424.0%   
Profit after tax Rs m1,027124 829.2%  
Gross profit margin %24.34.7 512.5%  
Effective tax rate %23.937.0 64.7%   
Net profit margin %13.93.0 467.1%  
BALANCE SHEET DATA
Current assets Rs m3,6811,629 226.0%   
Current liabilities Rs m3,1231,058 295.2%   
Net working cap to sales %7.613.7 55.1%  
Current ratio x1.21.5 76.6%  
Inventory Days Days8930 300.5%  
Debtors Days Days5934 174.7%  
Net fixed assets Rs m7,685556 1,381.5%   
Share capital Rs m33178 425.6%   
"Free" reserves Rs m6,670878 759.4%   
Net worth Rs m7,2591,069 678.8%   
Long term debt Rs m955159 601.7%   
Total assets Rs m11,9572,399 498.3%  
Interest coverage x4.57.6 59.7%   
Debt to equity ratio x0.10.1 88.6%  
Sales to assets ratio x0.61.7 35.6%   
Return on assets %11.76.4 181.8%  
Return on equity %14.211.6 122.2%  
Return on capital %20.718.5 112.3%  
Exports to sales %39.40.8 4,978.2%   
Imports to sales %5.71.4 406.9%   
Exports (fob) Rs m2,90833 8,838.3%   
Imports (cif) Rs m42158 722.5%   
Fx inflow Rs m3,44533 10,472.3%   
Fx outflow Rs m70363 1,112.2%   
Net fx Rs m2,743-30 -9,054.5%   
CASH FLOW
From Operations Rs m1,440127 1,137.7%  
From Investments Rs m-1,089-146 746.0%  
From Financial Activity Rs m-35322 -1,610.5%  
Net Cashflow Rs m-13 -59.6%  

Share Holding

Indian Promoters % 52.0 65.4 79.6%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 3.7 211.9%  
FIIs % 16.6 5.2 319.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 25.8 100.8%  
Shareholders   25,395 12,723 199.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare NATCO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; Banking Stocks Witness Buying Interest(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the energy sector.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jan 19, 2018 01:17 PM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - LUPIN LTD COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS